Zenas BioPharma, Inc. (ZBIO) reporting calendar
Zenas BioPharma, Inc. files periodic reports with the SEC as ZBIO on Nasdaq. Atlas tracks 7 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 27 Jul 2026 – 28 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 13 May 2026
- Reports on record
- 7
How this window is derived. Derived from this issuer's own filing history: 7 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open ZBIO market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 13 May 2026 | 43 days | 0001104659-26-059735 |
| 10-K | 31 Dec 2025 | 16 Mar 2026 | 75 days | 0001104659-26-027964 |
| 10-Q | 30 Sep 2025 | 12 Nov 2025 | 43 days | 0001104659-25-109753 |
| 10-Q | 30 Jun 2025 | 12 Aug 2025 | 43 days | 0001558370-25-011147 |
| 10-Q | 31 Mar 2025 | 15 May 2025 | 45 days | 0001558370-25-007803 |
| 10-K | 31 Dec 2024 | 11 Mar 2025 | 70 days | 0001558370-25-002631 |
| 10-Q | 30 Sep 2024 | 12 Nov 2024 | 43 days | 0001558370-24-015162 |
Source: SEC EDGAR company submissions for CIK 0001953926. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.